Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2011
03/16/2011CN101362796B B cell epitope of epididymal protease inhibitor and multiple antigenic peptide containing thereof
03/15/2011US7906484 Complex for transferring an anionic substance into a cell
03/15/2011US7906482 Peptide YY (PYY) coupled to a group capable of reacting on a blood component so as to form a stable covalent bond, preventing said PYY peptide from crossing the blood brain barrier; improved bioavailability; reduce tumor necrosis factor (TNF)-induced acute pancreatitis
03/15/2011US7906277 Compound and methods for diagnosis of tuberculosis
03/15/2011US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
03/15/2011CA2529062C Antimicrobial polypeptides
03/15/2011CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
03/10/2011WO2011028507A2 Compositions, methods, and kits for determining an alkyl transferase
03/10/2011WO2011027916A1 Therapeutic agent for allergic diseases
03/10/2011WO2011027868A1 Method for producing 11-sugar sialyloligosaccharide-peptide
03/10/2011WO2011027048A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same
03/10/2011WO2010108164A3 Novel anti-parasitic compounds
03/10/2011WO2010079511A4 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
03/10/2011US20110060124 Hla-binding peptides, precursors thereof, dna fragments and recombinant vectors that code for those peptide sequences
03/10/2011US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn
03/10/2011US20110059888 Metastin derivatives and use thereof
03/10/2011US20110059501 Protein Glycosylation
03/10/2011US20110059472 Reagents and methods for detecting influenza virus proteins
03/10/2011US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
03/10/2011US20110059091 Inhibitors of oncogenic isoforms and uses thereof
03/10/2011US20110059015 Vaccine
03/09/2011EP2292662A2 Assay and reagents for quantifying hBNP
03/09/2011EP2292655A1 Peptides and related molecules that bind to tall-1
03/09/2011EP2292642A1 Immunomodulating compositions, uses therefor and processes for their production
03/09/2011EP2292641A2 Expression in filamentous fungi of protease inhibitors and variants thereof
03/09/2011EP2292248A2 Anti-angiogenic compounds
03/09/2011EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
03/09/2011EP2291391A1 Use of a tpb salt for the separation of biomolecules
03/09/2011EP2291075A2 Gastrin releasing peptide compounds
03/09/2011EP1355910B1 Formulation of boronic acid compounds
03/09/2011CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent
03/08/2011US7902488 Microwave-assisted peptide synthesis
03/08/2011US7902344 Nucleotide sequences coding antibody specific for bacillus anthracis antigen for use in diagnosis, prevention and treatment of anthrax exposure; immunotherapy
03/08/2011US7902331 Forisomes, method for their isolation, and their use as a molecular working machine
03/08/2011US7902330 Protein kinase inhibitors and methods for identifying same
03/08/2011US7902329 Oligopeptide tyrosinase inhibitors and uses thereof
03/08/2011US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
03/08/2011US7902143 Cancer antigen peptide and the use thereof
03/08/2011US7901902 Methods and compositions for identifying a cellular immune response against prostate cancer
03/08/2011US7901894 Kinase inhibitors
03/03/2011WO2011026015A2 Stabilized melanocortin ligands
03/03/2011WO2011024482A1 Method for measurement of ability of inducing antigen-specific t cells
03/03/2011WO2011024428A1 Breast cancer related gene c12orf32
03/03/2011WO2010133806A3 Marked peptides and use thereof for assaying circulating irap
03/03/2011WO2010121023A3 Peptides and aptamers for targeting of neuron or nerves
03/03/2011US20110055942 Single domain TDF-related compounds and analogs thereof
03/03/2011US20110055940 Therapeutic Inhibitors of PAI-1 Function Methods of Their Use
03/03/2011US20110053864 Compositions and methods for modulation of cell migration
03/03/2011US20110053856 Metabolite derivatives of the hdac inhibitor fk228
03/03/2011US20110053849 Regulation of litaf modulated cytokine production by a novel p53 short peptide
03/03/2011US20110053846 The use of gnrh antagonist peptide in the treatement of sex hormone-dependent diseases
03/03/2011US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides
03/03/2011US20110053837 Mineral-peptide chelates
03/03/2011US20110053834 Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori and use thereof
03/03/2011US20110053833 Synthetic peptides and their use
03/03/2011US20110053829 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
03/03/2011US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator
03/03/2011US20110053225 Multifunctional tags
03/03/2011US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents
03/03/2011US20110053177 Mass spectrometric methods and products
03/03/2011US20110052692 Novel hydrogels and uses thereof
03/03/2011US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
03/03/2011US20110052615 Tumour-specific animal proteins
03/03/2011US20110052614 Stat3 epitope peptides
03/03/2011US20110052593 Breast cancer associated antigen
03/03/2011US20110052587 Peptide or protein comprising a c'-d loop of the cd28 receptor family
03/03/2011US20110052508 Peptide-based oral care surface reagents for personal care
03/03/2011US20110052491 Gastrin releasing peptide compounds
03/03/2011CA2809803A1 Stabilized melanocortin ligands
03/03/2011CA2772551A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
03/03/2011CA2772310A1 N-terminal dimerization methods with bis-amindino acid-and bis-thioimidate derivatives
03/02/2011EP2290077A2 Natural IGM antibodies and inhibitors thereof
03/02/2011EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications
03/02/2011EP2289905A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2alpha receptor
03/02/2011EP2289564A2 Derivatives of aniline as precursors for F18-labeling
03/02/2011EP2288621A2 Il-23 receptor antagonists and uses thereof
03/02/2011EP2288616A1 Peptidylarginine deiminase (pad) inhibitors
03/02/2011EP2288615A1 Selective caspase inhibitors and uses thereof
03/02/2011EP1934258B1 Antibodies against april as biomarkers for early prognosis of lymphoma patients
03/02/2011EP1844070B1 Peptides with neuropeptide-2 receptor (y2r) agonist activity
03/02/2011EP1673633B9 Method for detecting feline immunodeficiency virus
03/02/2011EP1587907B1 Kunitz domain library
03/02/2011EP1497452B1 Methods for measuring enzyme activity
03/02/2011EP1351992B1 Hybrid peptides for treatment of bacteremia and septicemia
03/02/2011CN1954068B HLA-binding peptide, precursor thereof, DNA fragment encoding the same and recombinant vector
03/02/2011CN101983205A Oxitocin analogues
03/01/2011US7897721 Cyclic peptide compositions for treatment of sexual dysfunction
02/2011
02/24/2011WO2011021581A1 Selective marker for target biopolymer
02/24/2011WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same
02/24/2011WO2011020596A2 Cyclosporine derivates
02/24/2011WO2011020188A1 Peptide sequences and peptide-mediated sirna delivery
02/24/2011WO2011020133A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases
02/24/2011US20110046070 Gene expression inhibitor selective for matrix metalloproteinase-9 gene
02/24/2011US20110046068 Compound, Use and Method
02/24/2011US20110046043 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
02/24/2011US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof
02/24/2011US20110046020 Novel ion channel-forming peptides
02/24/2011US20110045605 Characterization of Granulocytic Ehrlichia and Methods of Use
02/24/2011US20110045604 Molecular affinity clamp technology and uses thereof
02/24/2011US20110045538 Peptide, Use Of The Peptide, Method For The Production Of The Peptide, Solid Support Having The Peptide Immobilized Thereon, And Method For Production Of The Solid Support
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 423